Oxford University biotech spinouts Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
23:23
Jan 31
Jan 31
UK biotech cheap with global upside
UK biotech valuations are much lower than the US—at least half or more—yet the products are global. Steve relocated to Oxford and invests in Oxford University spinouts, giving him close local access to the Oxford, Cambridge, and London biotech clusters and cheap world-class IP.
HIGH
About Oxford University biotech spinouts Investor Commentary
Across the available history and selected sources, Buzzberg tracks Oxford University biotech spinouts across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Steve Diggle.